Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes

[1]  X. Shu,et al.  A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  N. Chatterjee,et al.  The HER2 I655V Polymorphism and Breast Cancer Risk in Ashkenazim , 2003, Epidemiology.

[3]  K. Lohman,et al.  DNA-repair genetic polymorphisms and breast cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  D. Cox,et al.  Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  D. Hunter,et al.  Polymorphic variation at the ‐202 locus in IGFBP3: Influence on serum levels of insulin‐like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk , 2003, International journal of cancer.

[6]  Jinghui Zhang,et al.  Mutational analysis of the BRCA1‐interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2‐negative probands from breast‐ovarian cancer families and among early‐onset breast cancer cases and reference individuals , 2003, Human mutation.

[7]  F. Berrino,et al.  Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  J. Chang-Claude,et al.  A Transforming Growth Factorβ1 Signal Peptide Variant Increases Secretion in Vitro and Is Associated with Increased Incidence of Invasive Breast Cancer , 2003 .

[9]  I. M. Jones,et al.  Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. , 2003, Mutation research.

[10]  C. Begg,et al.  Kin‐cohort evaluation of relative risks of genetic variants , 2003, Genetic epidemiology.

[11]  K. Lohman,et al.  Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. , 2003, Cancer letters.

[12]  A. Spurdle,et al.  BRCA2 arg372hispolymorphism and epithelial ovarian cancer risk , 2003, International journal of cancer.

[13]  C. Ulrich,et al.  Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  I. M. Jones,et al.  Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  D. Noh,et al.  XRCC1 genetic polymorphism and breast cancer risk. , 2002, Pharmacogenetics.

[16]  K. Caldecott,et al.  Central Role for the XRCC1 BRCT I Domain in Mammalian DNA Single-Strand Break Repair , 2002, Molecular and Cellular Biology.

[17]  G. Giles,et al.  The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  E. D. de Vries,et al.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility , 2002, Journal of medical genetics.

[19]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[20]  N E Day,et al.  Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study , 2001, Genetic epidemiology.

[21]  E. Ziv,et al.  Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures. , 2001, JAMA.

[22]  H. Mohrenweiser,et al.  Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. , 2001, Carcinogenesis.

[23]  E J Duell,et al.  Polymorphisms in the DNA repair gene XRCC1 and breast cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  S Wacholder,et al.  A Marginal Likelihood Approach for Estimating Penetrance from Kin‐Cohort Designs , 2001, Biometrics.

[25]  J. Chang-Claude,et al.  A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability , 2000, Nature Genetics.

[26]  M. West,et al.  XRCC1 keeps DNA from getting stranded. , 2000, Mutation research.

[27]  M. Gail,et al.  Kin-cohort designs for gene characterization. , 1999, Journal of the National Cancer Institute. Monographs.

[28]  D. Evans,et al.  Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? , 1999, American journal of human genetics.

[29]  D. Easton.  How many more breast cancer predisposition genes are there? , 1999, Breast Cancer Research.

[30]  Nazneen,et al.  Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.

[31]  D. Bell,et al.  XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. , 1999, Cancer research.

[32]  S Wacholder,et al.  The kin-cohort study for estimating penetrance. , 1998, American journal of epidemiology.

[33]  C. Mantzoros,et al.  Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. , 1998, Epidemiology.

[34]  I. M. Jones,et al.  Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? , 1998, Mutation research.

[35]  A. Sigurdson,et al.  Family history of cancer in patients with glioma: a validation study of accuracy. , 1998, Journal of the National Cancer Institute.

[36]  I. M. Jones,et al.  Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. , 1998, Cancer research.

[37]  L. Thompson,et al.  Life without DNA repair. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Arveiler,et al.  Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. , 1996, Hypertension.

[39]  A. Howell,et al.  Cancer experience in the relatives of an unselected series of breast cancer patients. , 1994, British Journal of Cancer.

[40]  Y. Hochberg.  A sharper Bonferroni procedure for multiple tests of significance , 1988 .

[41]  K. Shiraki,et al.  Breast cancer genetics: what we know and what we need , 2001, Nature Medicine.